Management & Regulatory

Gene Therapy Investment Falls Post-COVID, Showing Future Hope
Management & Regulatory Gene Therapy Investment Falls Post-COVID, Showing Future Hope

The gene therapy sector, once a beacon of hope for revolutionary treatments, has seen a significant slowdown in investment post the COVID-19 pandemic. This downturn follows a period of unprecedented financial influx during the pandemic years, raising questions about the future of this promising

Widespread Layoffs in Biopharma: Economic and Strategic Challenges
Management & Regulatory Widespread Layoffs in Biopharma: Economic and Strategic Challenges

The biopharma industry, renowned for its rapid innovation and significant contributions to healthcare, currently faces a tumultuous period marked by widespread layoffs. From early 2023 through late 2024, numerous companies have announced substantial workforce reductions, which reflect a time of

South Korea's Pharma Transformation: CDMOs and Biosimilars Surge
Management & Regulatory South Korea's Pharma Transformation: CDMOs and Biosimilars Surge

South Korea's pharmaceutical and biotech industry is witnessing a fascinating shift as Contract Development and Manufacturing Organizations (CDMOs) and biosimilar developers are experiencing robust growth, while traditional pharmaceutical companies lag. At the forefront of this transition is

Thermo Fisher to Open Advanced Bioprocess Center in Hyderabad
Management & Regulatory Thermo Fisher to Open Advanced Bioprocess Center in Hyderabad

Thermo Fisher Scientific is making significant strides in the Indian biopharma market with the announcement of a new bioprocess design center (BDC) in Genome Valley, Hyderabad. This 10,000 square-foot facility, expected to open early next year, is part of a broader initiative by the company to

Is Sanofi’s Shift to Pure Biopharma the Future of Healthcare Innovation?
Management & Regulatory Is Sanofi’s Shift to Pure Biopharma the Future of Healthcare Innovation?

In October 2023, Sanofi, a leading global pharmaceutical company, announced a major shift in its business strategy. This shift involved the separation of its consumer health division, a move set to be completed in 2024. Historically, Sanofi's consumer health division, which includes popular

Fujifilm Diosynth To Expand Hillerød Facility, Adding 2,200 Jobs
Management & Regulatory Fujifilm Diosynth To Expand Hillerød Facility, Adding 2,200 Jobs

Fujifilm Diosynth Biotechnologies, a leading CDMO in the field of biologics, vaccines, advanced therapies, and oncolytic viruses, has embarked on the initial phase of a massive expansion project at their facility in Hillerød, Denmark. By adding six mammalian cell bioreactors to the existing

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later